Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2024-2030

Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2024-2030

Page: 114

Published Date: 14 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Immuno-oncology Clinical Trials market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The growth can be attributed to recent developments in immuno-oncology, changes in lifestyle brought on by urbanization predisposing populations to the rise of cancer, and the growing acceptability of targeted therapy.

This report studies the global Immuno-oncology Clinical Trials demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Immuno-oncology Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immuno-oncology Clinical Trials that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Immuno-oncology Clinical Trials total market, 2019-2030, (USD Million)
Global Immuno-oncology Clinical Trials total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Immuno-oncology Clinical Trials total market, key domestic companies and share, (USD Million)
Global Immuno-oncology Clinical Trials revenue by player and market share 2019-2024, (USD Million)
Global Immuno-oncology Clinical Trials total market by Type, CAGR, 2019-2030, (USD Million)
Global Immuno-oncology Clinical Trials total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Immuno-oncology Clinical Trials market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, ICON plc, IQVIA Holdings, BioNtech and Covance, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immuno-oncology Clinical Trials market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Immuno-oncology Clinical Trials Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Immuno-oncology Clinical Trials Market, Segmentation by Type
Phase I
Phase II
Phase III
Phase IV

Global Immuno-oncology Clinical Trials Market, Segmentation by Application
Solid Tumors
Hematological Cancer

Companies Profiled:
Medpace
Novartis
Exscientia
Syneous Health
AstraZeneca
ICON plc
IQVIA Holdings
BioNtech
Covance, Inc.
IO BIOTECH

Key Questions Answered
1. How big is the global Immuno-oncology Clinical Trials market?
2. What is the demand of the global Immuno-oncology Clinical Trials market?
3. What is the year over year growth of the global Immuno-oncology Clinical Trials market?
4. What is the total value of the global Immuno-oncology Clinical Trials market?
5. Who are the major players in the global Immuno-oncology Clinical Trials market?
btl

Table of Contents

1 Supply Summary
1.1 Immuno-oncology Clinical Trials Introduction
1.2 World Immuno-oncology Clinical Trials Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Immuno-oncology Clinical Trials Total Market by Region (by Headquarter Location)
1.3.1 World Immuno-oncology Clinical Trials Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.3 China Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.4 Europe Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.5 Japan Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.6 South Korea Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.7 ASEAN Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.8 India Immuno-oncology Clinical Trials Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immuno-oncology Clinical Trials Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immuno-oncology Clinical Trials Major Market Trends

2 Demand Summary
2.1 World Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.2 World Immuno-oncology Clinical Trials Consumption Value by Region
2.2.1 World Immuno-oncology Clinical Trials Consumption Value by Region (2019-2024)
2.2.2 World Immuno-oncology Clinical Trials Consumption Value Forecast by Region (2025-2030)
2.3 United States Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.4 China Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.5 Europe Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.6 Japan Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.7 South Korea Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.8 ASEAN Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.9 India Immuno-oncology Clinical Trials Consumption Value (2019-2030)

3 World Immuno-oncology Clinical Trials Companies Competitive Analysis
3.1 World Immuno-oncology Clinical Trials Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immuno-oncology Clinical Trials Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immuno-oncology Clinical Trials in 2023
3.2.3 Global Concentration Ratios (CR8) for Immuno-oncology Clinical Trials in 2023
3.3 Immuno-oncology Clinical Trials Company Evaluation Quadrant
3.4 Immuno-oncology Clinical Trials Market: Overall Company Footprint Analysis
3.4.1 Immuno-oncology Clinical Trials Market: Region Footprint
3.4.2 Immuno-oncology Clinical Trials Market: Company Product Type Footprint
3.4.3 Immuno-oncology Clinical Trials Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Immuno-oncology Clinical Trials Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immuno-oncology Clinical Trials Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Immuno-oncology Clinical Trials Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Immuno-oncology Clinical Trials Consumption Value Comparison
4.2.1 United States VS China: Immuno-oncology Clinical Trials Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Immuno-oncology Clinical Trials Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Immuno-oncology Clinical Trials Companies and Market Share, 2019-2024
4.3.1 United States Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024)
4.4 China Based Companies Immuno-oncology Clinical Trials Revenue and Market Share, 2019-2024
4.4.1 China Based Immuno-oncology Clinical Trials Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024)
4.5 Rest of World Based Immuno-oncology Clinical Trials Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Immuno-oncology Clinical Trials Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Phase I
5.2.2 Phase II
5.2.3 Phase III
5.2.4 Phase IV
5.3 Market Segment by Type
5.3.1 World Immuno-oncology Clinical Trials Market Size by Type (2019-2024)
5.3.2 World Immuno-oncology Clinical Trials Market Size by Type (2025-2030)
5.3.3 World Immuno-oncology Clinical Trials Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Immuno-oncology Clinical Trials Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Solid Tumors
6.2.2 Hematological Cancer
6.3 Market Segment by Application
6.3.1 World Immuno-oncology Clinical Trials Market Size by Application (2019-2024)
6.3.2 World Immuno-oncology Clinical Trials Market Size by Application (2025-2030)
6.3.3 World Immuno-oncology Clinical Trials Market Size by Application (2019-2030)

7 Company Profiles
7.1 Medpace
7.1.1 Medpace Details
7.1.2 Medpace Major Business
7.1.3 Medpace Immuno-oncology Clinical Trials Product and Services
7.1.4 Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Medpace Recent Developments/Updates
7.1.6 Medpace Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Immuno-oncology Clinical Trials Product and Services
7.2.4 Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Exscientia
7.3.1 Exscientia Details
7.3.2 Exscientia Major Business
7.3.3 Exscientia Immuno-oncology Clinical Trials Product and Services
7.3.4 Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Exscientia Recent Developments/Updates
7.3.6 Exscientia Competitive Strengths & Weaknesses
7.4 Syneous Health
7.4.1 Syneous Health Details
7.4.2 Syneous Health Major Business
7.4.3 Syneous Health Immuno-oncology Clinical Trials Product and Services
7.4.4 Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Syneous Health Recent Developments/Updates
7.4.6 Syneous Health Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Immuno-oncology Clinical Trials Product and Services
7.5.4 AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 ICON plc
7.6.1 ICON plc Details
7.6.2 ICON plc Major Business
7.6.3 ICON plc Immuno-oncology Clinical Trials Product and Services
7.6.4 ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 ICON plc Recent Developments/Updates
7.6.6 ICON plc Competitive Strengths & Weaknesses
7.7 IQVIA Holdings
7.7.1 IQVIA Holdings Details
7.7.2 IQVIA Holdings Major Business
7.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Product and Services
7.7.4 IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 IQVIA Holdings Recent Developments/Updates
7.7.6 IQVIA Holdings Competitive Strengths & Weaknesses
7.8 BioNtech
7.8.1 BioNtech Details
7.8.2 BioNtech Major Business
7.8.3 BioNtech Immuno-oncology Clinical Trials Product and Services
7.8.4 BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 BioNtech Recent Developments/Updates
7.8.6 BioNtech Competitive Strengths & Weaknesses
7.9 Covance, Inc.
7.9.1 Covance, Inc. Details
7.9.2 Covance, Inc. Major Business
7.9.3 Covance, Inc. Immuno-oncology Clinical Trials Product and Services
7.9.4 Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Covance, Inc. Recent Developments/Updates
7.9.6 Covance, Inc. Competitive Strengths & Weaknesses
7.10 IO BIOTECH
7.10.1 IO BIOTECH Details
7.10.2 IO BIOTECH Major Business
7.10.3 IO BIOTECH Immuno-oncology Clinical Trials Product and Services
7.10.4 IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 IO BIOTECH Recent Developments/Updates
7.10.6 IO BIOTECH Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Immuno-oncology Clinical Trials Industry Chain
8.2 Immuno-oncology Clinical Trials Upstream Analysis
8.3 Immuno-oncology Clinical Trials Midstream Analysis
8.4 Immuno-oncology Clinical Trials Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Immuno-oncology Clinical Trials Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Immuno-oncology Clinical Trials Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Immuno-oncology Clinical Trials Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immuno-oncology Clinical Trials Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Immuno-oncology Clinical Trials Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Immuno-oncology Clinical Trials Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Immuno-oncology Clinical Trials Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Immuno-oncology Clinical Trials Players in 2023
Table 12. World Immuno-oncology Clinical Trials Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Immuno-oncology Clinical Trials Company Evaluation Quadrant
Table 14. Head Office of Key Immuno-oncology Clinical Trials Player
Table 15. Immuno-oncology Clinical Trials Market: Company Product Type Footprint
Table 16. Immuno-oncology Clinical Trials Market: Company Product Application Footprint
Table 17. Immuno-oncology Clinical Trials Mergers & Acquisitions Activity
Table 18. United States VS China Immuno-oncology Clinical Trials Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Immuno-oncology Clinical Trials Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2019-2024)
Table 23. China Based Immuno-oncology Clinical Trials Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2019-2024)
Table 26. Rest of World Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2019-2024)
Table 29. World Immuno-oncology Clinical Trials Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Immuno-oncology Clinical Trials Market Size by Type (2019-2024) & (USD Million)
Table 31. World Immuno-oncology Clinical Trials Market Size by Type (2025-2030) & (USD Million)
Table 32. World Immuno-oncology Clinical Trials Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Immuno-oncology Clinical Trials Market Size by Application (2019-2024) & (USD Million)
Table 34. World Immuno-oncology Clinical Trials Market Size by Application (2025-2030) & (USD Million)
Table 35. Medpace Basic Information, Area Served and Competitors
Table 36. Medpace Major Business
Table 37. Medpace Immuno-oncology Clinical Trials Product and Services
Table 38. Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Medpace Recent Developments/Updates
Table 40. Medpace Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Immuno-oncology Clinical Trials Product and Services
Table 44. Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Exscientia Basic Information, Area Served and Competitors
Table 48. Exscientia Major Business
Table 49. Exscientia Immuno-oncology Clinical Trials Product and Services
Table 50. Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Exscientia Recent Developments/Updates
Table 52. Exscientia Competitive Strengths & Weaknesses
Table 53. Syneous Health Basic Information, Area Served and Competitors
Table 54. Syneous Health Major Business
Table 55. Syneous Health Immuno-oncology Clinical Trials Product and Services
Table 56. Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Syneous Health Recent Developments/Updates
Table 58. Syneous Health Competitive Strengths & Weaknesses
Table 59. AstraZeneca Basic Information, Area Served and Competitors
Table 60. AstraZeneca Major Business
Table 61. AstraZeneca Immuno-oncology Clinical Trials Product and Services
Table 62. AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. AstraZeneca Recent Developments/Updates
Table 64. AstraZeneca Competitive Strengths & Weaknesses
Table 65. ICON plc Basic Information, Area Served and Competitors
Table 66. ICON plc Major Business
Table 67. ICON plc Immuno-oncology Clinical Trials Product and Services
Table 68. ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. ICON plc Recent Developments/Updates
Table 70. ICON plc Competitive Strengths & Weaknesses
Table 71. IQVIA Holdings Basic Information, Area Served and Competitors
Table 72. IQVIA Holdings Major Business
Table 73. IQVIA Holdings Immuno-oncology Clinical Trials Product and Services
Table 74. IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. IQVIA Holdings Recent Developments/Updates
Table 76. IQVIA Holdings Competitive Strengths & Weaknesses
Table 77. BioNtech Basic Information, Area Served and Competitors
Table 78. BioNtech Major Business
Table 79. BioNtech Immuno-oncology Clinical Trials Product and Services
Table 80. BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. BioNtech Recent Developments/Updates
Table 82. BioNtech Competitive Strengths & Weaknesses
Table 83. Covance, Inc. Basic Information, Area Served and Competitors
Table 84. Covance, Inc. Major Business
Table 85. Covance, Inc. Immuno-oncology Clinical Trials Product and Services
Table 86. Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Covance, Inc. Recent Developments/Updates
Table 88. IO BIOTECH Basic Information, Area Served and Competitors
Table 89. IO BIOTECH Major Business
Table 90. IO BIOTECH Immuno-oncology Clinical Trials Product and Services
Table 91. IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 92. Global Key Players of Immuno-oncology Clinical Trials Upstream (Raw Materials)
Table 93. Immuno-oncology Clinical Trials Typical Customers
List of Figure
Figure 1. Immuno-oncology Clinical Trials Picture
Figure 2. World Immuno-oncology Clinical Trials Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Immuno-oncology Clinical Trials Total Market Size (2019-2030) & (USD Million)
Figure 4. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 13. Immuno-oncology Clinical Trials Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 16. World Immuno-oncology Clinical Trials Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 18. China Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 23. India Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Immuno-oncology Clinical Trials by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immuno-oncology Clinical Trials Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immuno-oncology Clinical Trials Markets in 2023
Figure 27. United States VS China: Immuno-oncology Clinical Trials Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Immuno-oncology Clinical Trials Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Immuno-oncology Clinical Trials Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Immuno-oncology Clinical Trials Market Size Market Share by Type in 2023
Figure 31. Phase I
Figure 32. Phase II
Figure 33. Phase III
Figure 34. Phase IV
Figure 35. World Immuno-oncology Clinical Trials Market Size Market Share by Type (2019-2030)
Figure 36. World Immuno-oncology Clinical Trials Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Immuno-oncology Clinical Trials Market Size Market Share by Application in 2023
Figure 38. Solid Tumors
Figure 39. Hematological Cancer
Figure 40. Immuno-oncology Clinical Trials Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Medpace
Novartis
Exscientia
Syneous Health
AstraZeneca
ICON plc
IQVIA Holdings
BioNtech
Covance, Inc.
IO BIOTECH
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2024-2030

Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2024-2030

Page: 114

Published Date: 14 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Immuno-oncology Clinical Trials market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The growth can be attributed to recent developments in immuno-oncology, changes in lifestyle brought on by urbanization predisposing populations to the rise of cancer, and the growing acceptability of targeted therapy.

This report studies the global Immuno-oncology Clinical Trials demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Immuno-oncology Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immuno-oncology Clinical Trials that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Immuno-oncology Clinical Trials total market, 2019-2030, (USD Million)
Global Immuno-oncology Clinical Trials total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Immuno-oncology Clinical Trials total market, key domestic companies and share, (USD Million)
Global Immuno-oncology Clinical Trials revenue by player and market share 2019-2024, (USD Million)
Global Immuno-oncology Clinical Trials total market by Type, CAGR, 2019-2030, (USD Million)
Global Immuno-oncology Clinical Trials total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Immuno-oncology Clinical Trials market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, ICON plc, IQVIA Holdings, BioNtech and Covance, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immuno-oncology Clinical Trials market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Immuno-oncology Clinical Trials Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Immuno-oncology Clinical Trials Market, Segmentation by Type
Phase I
Phase II
Phase III
Phase IV

Global Immuno-oncology Clinical Trials Market, Segmentation by Application
Solid Tumors
Hematological Cancer

Companies Profiled:
Medpace
Novartis
Exscientia
Syneous Health
AstraZeneca
ICON plc
IQVIA Holdings
BioNtech
Covance, Inc.
IO BIOTECH

Key Questions Answered
1. How big is the global Immuno-oncology Clinical Trials market?
2. What is the demand of the global Immuno-oncology Clinical Trials market?
3. What is the year over year growth of the global Immuno-oncology Clinical Trials market?
4. What is the total value of the global Immuno-oncology Clinical Trials market?
5. Who are the major players in the global Immuno-oncology Clinical Trials market?
btl

Table of Contents

1 Supply Summary
1.1 Immuno-oncology Clinical Trials Introduction
1.2 World Immuno-oncology Clinical Trials Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Immuno-oncology Clinical Trials Total Market by Region (by Headquarter Location)
1.3.1 World Immuno-oncology Clinical Trials Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.3 China Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.4 Europe Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.5 Japan Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.6 South Korea Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.7 ASEAN Immuno-oncology Clinical Trials Market Size (2019-2030)
1.3.8 India Immuno-oncology Clinical Trials Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immuno-oncology Clinical Trials Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immuno-oncology Clinical Trials Major Market Trends

2 Demand Summary
2.1 World Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.2 World Immuno-oncology Clinical Trials Consumption Value by Region
2.2.1 World Immuno-oncology Clinical Trials Consumption Value by Region (2019-2024)
2.2.2 World Immuno-oncology Clinical Trials Consumption Value Forecast by Region (2025-2030)
2.3 United States Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.4 China Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.5 Europe Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.6 Japan Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.7 South Korea Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.8 ASEAN Immuno-oncology Clinical Trials Consumption Value (2019-2030)
2.9 India Immuno-oncology Clinical Trials Consumption Value (2019-2030)

3 World Immuno-oncology Clinical Trials Companies Competitive Analysis
3.1 World Immuno-oncology Clinical Trials Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immuno-oncology Clinical Trials Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immuno-oncology Clinical Trials in 2023
3.2.3 Global Concentration Ratios (CR8) for Immuno-oncology Clinical Trials in 2023
3.3 Immuno-oncology Clinical Trials Company Evaluation Quadrant
3.4 Immuno-oncology Clinical Trials Market: Overall Company Footprint Analysis
3.4.1 Immuno-oncology Clinical Trials Market: Region Footprint
3.4.2 Immuno-oncology Clinical Trials Market: Company Product Type Footprint
3.4.3 Immuno-oncology Clinical Trials Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Immuno-oncology Clinical Trials Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immuno-oncology Clinical Trials Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Immuno-oncology Clinical Trials Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Immuno-oncology Clinical Trials Consumption Value Comparison
4.2.1 United States VS China: Immuno-oncology Clinical Trials Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Immuno-oncology Clinical Trials Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Immuno-oncology Clinical Trials Companies and Market Share, 2019-2024
4.3.1 United States Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024)
4.4 China Based Companies Immuno-oncology Clinical Trials Revenue and Market Share, 2019-2024
4.4.1 China Based Immuno-oncology Clinical Trials Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024)
4.5 Rest of World Based Immuno-oncology Clinical Trials Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Immuno-oncology Clinical Trials Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Phase I
5.2.2 Phase II
5.2.3 Phase III
5.2.4 Phase IV
5.3 Market Segment by Type
5.3.1 World Immuno-oncology Clinical Trials Market Size by Type (2019-2024)
5.3.2 World Immuno-oncology Clinical Trials Market Size by Type (2025-2030)
5.3.3 World Immuno-oncology Clinical Trials Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Immuno-oncology Clinical Trials Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Solid Tumors
6.2.2 Hematological Cancer
6.3 Market Segment by Application
6.3.1 World Immuno-oncology Clinical Trials Market Size by Application (2019-2024)
6.3.2 World Immuno-oncology Clinical Trials Market Size by Application (2025-2030)
6.3.3 World Immuno-oncology Clinical Trials Market Size by Application (2019-2030)

7 Company Profiles
7.1 Medpace
7.1.1 Medpace Details
7.1.2 Medpace Major Business
7.1.3 Medpace Immuno-oncology Clinical Trials Product and Services
7.1.4 Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Medpace Recent Developments/Updates
7.1.6 Medpace Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Immuno-oncology Clinical Trials Product and Services
7.2.4 Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Exscientia
7.3.1 Exscientia Details
7.3.2 Exscientia Major Business
7.3.3 Exscientia Immuno-oncology Clinical Trials Product and Services
7.3.4 Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Exscientia Recent Developments/Updates
7.3.6 Exscientia Competitive Strengths & Weaknesses
7.4 Syneous Health
7.4.1 Syneous Health Details
7.4.2 Syneous Health Major Business
7.4.3 Syneous Health Immuno-oncology Clinical Trials Product and Services
7.4.4 Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Syneous Health Recent Developments/Updates
7.4.6 Syneous Health Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Immuno-oncology Clinical Trials Product and Services
7.5.4 AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 ICON plc
7.6.1 ICON plc Details
7.6.2 ICON plc Major Business
7.6.3 ICON plc Immuno-oncology Clinical Trials Product and Services
7.6.4 ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 ICON plc Recent Developments/Updates
7.6.6 ICON plc Competitive Strengths & Weaknesses
7.7 IQVIA Holdings
7.7.1 IQVIA Holdings Details
7.7.2 IQVIA Holdings Major Business
7.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Product and Services
7.7.4 IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 IQVIA Holdings Recent Developments/Updates
7.7.6 IQVIA Holdings Competitive Strengths & Weaknesses
7.8 BioNtech
7.8.1 BioNtech Details
7.8.2 BioNtech Major Business
7.8.3 BioNtech Immuno-oncology Clinical Trials Product and Services
7.8.4 BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 BioNtech Recent Developments/Updates
7.8.6 BioNtech Competitive Strengths & Weaknesses
7.9 Covance, Inc.
7.9.1 Covance, Inc. Details
7.9.2 Covance, Inc. Major Business
7.9.3 Covance, Inc. Immuno-oncology Clinical Trials Product and Services
7.9.4 Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Covance, Inc. Recent Developments/Updates
7.9.6 Covance, Inc. Competitive Strengths & Weaknesses
7.10 IO BIOTECH
7.10.1 IO BIOTECH Details
7.10.2 IO BIOTECH Major Business
7.10.3 IO BIOTECH Immuno-oncology Clinical Trials Product and Services
7.10.4 IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 IO BIOTECH Recent Developments/Updates
7.10.6 IO BIOTECH Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Immuno-oncology Clinical Trials Industry Chain
8.2 Immuno-oncology Clinical Trials Upstream Analysis
8.3 Immuno-oncology Clinical Trials Midstream Analysis
8.4 Immuno-oncology Clinical Trials Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Immuno-oncology Clinical Trials Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Immuno-oncology Clinical Trials Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Immuno-oncology Clinical Trials Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immuno-oncology Clinical Trials Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Immuno-oncology Clinical Trials Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Immuno-oncology Clinical Trials Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Immuno-oncology Clinical Trials Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Immuno-oncology Clinical Trials Players in 2023
Table 12. World Immuno-oncology Clinical Trials Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Immuno-oncology Clinical Trials Company Evaluation Quadrant
Table 14. Head Office of Key Immuno-oncology Clinical Trials Player
Table 15. Immuno-oncology Clinical Trials Market: Company Product Type Footprint
Table 16. Immuno-oncology Clinical Trials Market: Company Product Application Footprint
Table 17. Immuno-oncology Clinical Trials Mergers & Acquisitions Activity
Table 18. United States VS China Immuno-oncology Clinical Trials Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Immuno-oncology Clinical Trials Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2019-2024)
Table 23. China Based Immuno-oncology Clinical Trials Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2019-2024)
Table 26. Rest of World Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Immuno-oncology Clinical Trials Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2019-2024)
Table 29. World Immuno-oncology Clinical Trials Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Immuno-oncology Clinical Trials Market Size by Type (2019-2024) & (USD Million)
Table 31. World Immuno-oncology Clinical Trials Market Size by Type (2025-2030) & (USD Million)
Table 32. World Immuno-oncology Clinical Trials Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Immuno-oncology Clinical Trials Market Size by Application (2019-2024) & (USD Million)
Table 34. World Immuno-oncology Clinical Trials Market Size by Application (2025-2030) & (USD Million)
Table 35. Medpace Basic Information, Area Served and Competitors
Table 36. Medpace Major Business
Table 37. Medpace Immuno-oncology Clinical Trials Product and Services
Table 38. Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Medpace Recent Developments/Updates
Table 40. Medpace Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Immuno-oncology Clinical Trials Product and Services
Table 44. Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Exscientia Basic Information, Area Served and Competitors
Table 48. Exscientia Major Business
Table 49. Exscientia Immuno-oncology Clinical Trials Product and Services
Table 50. Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Exscientia Recent Developments/Updates
Table 52. Exscientia Competitive Strengths & Weaknesses
Table 53. Syneous Health Basic Information, Area Served and Competitors
Table 54. Syneous Health Major Business
Table 55. Syneous Health Immuno-oncology Clinical Trials Product and Services
Table 56. Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Syneous Health Recent Developments/Updates
Table 58. Syneous Health Competitive Strengths & Weaknesses
Table 59. AstraZeneca Basic Information, Area Served and Competitors
Table 60. AstraZeneca Major Business
Table 61. AstraZeneca Immuno-oncology Clinical Trials Product and Services
Table 62. AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. AstraZeneca Recent Developments/Updates
Table 64. AstraZeneca Competitive Strengths & Weaknesses
Table 65. ICON plc Basic Information, Area Served and Competitors
Table 66. ICON plc Major Business
Table 67. ICON plc Immuno-oncology Clinical Trials Product and Services
Table 68. ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. ICON plc Recent Developments/Updates
Table 70. ICON plc Competitive Strengths & Weaknesses
Table 71. IQVIA Holdings Basic Information, Area Served and Competitors
Table 72. IQVIA Holdings Major Business
Table 73. IQVIA Holdings Immuno-oncology Clinical Trials Product and Services
Table 74. IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. IQVIA Holdings Recent Developments/Updates
Table 76. IQVIA Holdings Competitive Strengths & Weaknesses
Table 77. BioNtech Basic Information, Area Served and Competitors
Table 78. BioNtech Major Business
Table 79. BioNtech Immuno-oncology Clinical Trials Product and Services
Table 80. BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. BioNtech Recent Developments/Updates
Table 82. BioNtech Competitive Strengths & Weaknesses
Table 83. Covance, Inc. Basic Information, Area Served and Competitors
Table 84. Covance, Inc. Major Business
Table 85. Covance, Inc. Immuno-oncology Clinical Trials Product and Services
Table 86. Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Covance, Inc. Recent Developments/Updates
Table 88. IO BIOTECH Basic Information, Area Served and Competitors
Table 89. IO BIOTECH Major Business
Table 90. IO BIOTECH Immuno-oncology Clinical Trials Product and Services
Table 91. IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 92. Global Key Players of Immuno-oncology Clinical Trials Upstream (Raw Materials)
Table 93. Immuno-oncology Clinical Trials Typical Customers
List of Figure
Figure 1. Immuno-oncology Clinical Trials Picture
Figure 2. World Immuno-oncology Clinical Trials Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Immuno-oncology Clinical Trials Total Market Size (2019-2030) & (USD Million)
Figure 4. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Immuno-oncology Clinical Trials Revenue (2019-2030) & (USD Million)
Figure 13. Immuno-oncology Clinical Trials Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 16. World Immuno-oncology Clinical Trials Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 18. China Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 23. India Immuno-oncology Clinical Trials Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Immuno-oncology Clinical Trials by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immuno-oncology Clinical Trials Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immuno-oncology Clinical Trials Markets in 2023
Figure 27. United States VS China: Immuno-oncology Clinical Trials Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Immuno-oncology Clinical Trials Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Immuno-oncology Clinical Trials Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Immuno-oncology Clinical Trials Market Size Market Share by Type in 2023
Figure 31. Phase I
Figure 32. Phase II
Figure 33. Phase III
Figure 34. Phase IV
Figure 35. World Immuno-oncology Clinical Trials Market Size Market Share by Type (2019-2030)
Figure 36. World Immuno-oncology Clinical Trials Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Immuno-oncology Clinical Trials Market Size Market Share by Application in 2023
Figure 38. Solid Tumors
Figure 39. Hematological Cancer
Figure 40. Immuno-oncology Clinical Trials Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Medpace
Novartis
Exscientia
Syneous Health
AstraZeneca
ICON plc
IQVIA Holdings
BioNtech
Covance, Inc.
IO BIOTECH
jiaGou

Add To Cart

gouMai

Buy Now